Aqueous extract of Solanum nigrum leaf activates autophagic cell death and enhances docetaxel-induced cytotoxicity in human endometrial carcinoma cells

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Tai, Cheng Jeng ^a,b   Wang, Chien Kai ^a,b   Chang, Yu Jia ^a,b   Lin, Chi Shian ^b   Tai, Chen Jei ^a,b  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DOCETAXEL; MICROTUBULE ASSOCIATED PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SOLANUM NIGRUM EXTRACT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; AUTOPHAGY; CANCER CELL; CELL DEATH; CELL VIABILITY; CYTOTOXICITY; DRUG POTENTIATION; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN CELL; PLANT LEAF; PRIORITY JOURNAL; SOLANUM NIGRUM;

EID: 84870153027     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/859185     Document Type: Article

References (33)

1. Amant F., Moerman P., Neven P., Timmerman D., Van Limbergen E., Vergote I., Endometrial cancer. The Lancet 2005 366 9484 491 505 2-s2.0-23444461364 10.1016/S0140-6736(05)67063-8 (Pubitemid 41111699)
2. Bray F., Loos A. H., Oostindier M., Weiderpass E., Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe. International Journal of Cancer 2005 117 1 123 131 2-s2.0-18544373204 10.1002/ijc.21099 (Pubitemid 41262766)
3. Creasman W., Odicino F., Maisonneuve P., Quinn M., Beller U., Benedet J., Heintz A., Ngan H., Pecorelli S., Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynecology and Obstetrics 2006 95 supplement 1 S105 S143 2-s2.0-33845229580 10.1016/S0020-7292(06)60031-3 (Pubitemid 44854931)
4. Randall M. E., Filiaci V. L., Muss H., Spirtos N. M., Mannel R. S., Fowler J., Thigpen J. T., Benda J. A., Mackey D., Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. Journal of Clinical Oncology 2006 24 1 36 44 2-s2.0-33644836069 10.1200/JCO.2004.00.7617 (Pubitemid 46630491)
5. Aalders J. G., Abeler V., Kolstad P., Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecologic Oncology 1984 17 1 85 103 2-s2.0-0021349366 (Pubitemid 14176295)
6. Podratz K. C., O'Brien P. C., Malkasian G. D. Jr., Effects of progestational agents in treatment of endometrial carcinoma. Obstetrics and Gynecology 1985 66 1 106 110 2-s2.0-0021843010 (Pubitemid 15047395)
7. Secord A. A., Havrilesky L. J., Bae-Jump V., Chin J., Calingaert B., Bland A., Rutledge T. L., Berchuck A., Clarke-Pearson D. L., Gehrig P. A., The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecologic Oncology 2007 107 2 285 291 2-s2.0-35348853994 10.1016/j.ygyno.2007.06.014 (Pubitemid 47575727)
8. Bruzzone M., Miglietta L., Franzone P., Gadducci A., Boccardo F., Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients. Gynecologic Oncology 2004 93 2 345 352 2-s2.0-1942476922 10.1016/j.ygyno.2004.02.008 (Pubitemid 38507600)
9. Nomura H., Aoki D., Takahashi F., Katsumata N., Watanabe Y., Konishi I., Jobo T., Hatae M., Hiura M., Yaegashi N., Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041). Annals of Oncology 2011 22 3 636 642 2-s2.0-79952027743 10.1093/annonc/mdq401
10. Ernst E., Cassileth B. R., The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998 83 777 782 (Pubitemid 28387704)
11. Patterson R. E., Neuhouser M. L., Hedderson M. M., Schwartz S. M., Standish L. J., Bowen D. J., Marshall L. M., Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. Journal of Alternative and Complementary Medicine 2002 8 4 477 485 2-s2.0-0036671657 (Pubitemid 34994542)
12. Richardson M. A., Sanders T., Palmer J. L., Greisinger A., Singletary S. E., Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. Journal of Clinical Oncology 2000 18 13 2505 2514 2-s2.0-0033918159 (Pubitemid 30432515)
13. Xu W., Towers A. D., Li P., Collet J. P., Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. European Journal of Cancer Care 2006 15 4 397 403 2-s2.0-33748513702 10.1111/j.1365-2354.2006.00685.x (Pubitemid 44359404)
14. Qi F., Li A., Inagaki Y., Gao J., Li J., Kokudo N., Li X. K., Tang W., Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Bioscience Trends 2010 4 6 297 307 2-s2.0-79955655749
15. Youns M., Hoheisel J. D., Efferth T., Traditional Chinese Medicines (TCMs) for molecular targeted therapies of tumours. Current Drug Discovery Technologies 2010 7 1 37 45 2-s2.0-77951748113 10.2174/157016310791162730
16. An L., Tang J. T., Liu X. M., Gao N. N., Review about mechanisms of anti-cancer of Solanum nigrum. Zhongguo Zhongyao Zazhi 2006 31 15 1225 1260 2-s2.0-33846331248
17. Huang H. C., Syu K. Y., Lin J. K., Chemical composition of Solanum nigrum linn extract and induction of autophagy by leaf water extract and its major flavonoids in AU565 breast cancer cells. Journal of Agricultural and Food Chemistry 2010 58 15 8699 8708 2-s2.0-77955700152 10.1021/jf101003v
18. Shokrzadeh M., Azadbakht M., Ahangar N., Hashemi A., Saravi S. S. S., Cytotoxicity of hydro-alcoholic extracts of Cucurbita pepo and Solanum nigrum on HepG2 and CT26 cancer cell lines. Pharmacognosy Magazine 2010 6 23 176 179 2-s2.0-78049401745 10.4103/0973-1296.66931
19. Lin H. M., Tseng H. C., Wang C. J., Chyau C. C., Liao K. K., Peng P. L., Chou F. P., Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells. Journal of Agricultural and Food Chemistry 2007 55 9 3620 3628 2-s2.0-34249342311 10.1021/jf062406m (Pubitemid 46806584)
20. Ganansia-Leymarie V., Bischoff P., Bergerat J. P., Holl V., Signal transduction pathways of taxanes-induced apoptosis. Current Medicinal Chemistry 2003 3 4 291 306 2-s2.0-0037868278 10.2174/1568011033482422 (Pubitemid 36758303)
21. Zhang F., Zhang T., Qu Y., Jiang T., Cao Y. X., Li C., Fan L., Mei Q. B., Replication-dependent γ -H2AX formation is involved in docetaxel-induced apoptosis in NSCLC A549 cells. Oncology Reports 2010 24 5 1297 1305 2-s2.0-78149333462 10.3892/or-00000986
22. Chou T. C., Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacological Reviews 2006 58 3 621 681 2-s2.0-33748794547 10.1124/pr.58.3.10 (Pubitemid 44403686)
23. 2/M phase arrest and apoptosis. Journal of the Science of Food and Agriculture 2011 91 1 178 185 2-s2.0-78649428161 10.1002/jsfa.4170
24. Horne A. W., Lalani E. N., Margara R. A., White J. O., The effects of sex steroid hormones and interleukin-1-beta on MUC1 expression in endometrial epithelial cell lines. Reproduction 2006 131 4 733 742 2-s2.0-33646270879 10.1530/rep.1.00883
25. Watanabe A., Kinoshita Y., Hosokawa K., Mori T., Yamaguchi T., Honjo H., Function of estrogen-related receptor α in human endometrial cancer. Journal of Clinical Endocrinology and Metabolism 2006 91 4 1573 1577 2-s2.0-33646070946 10.1210/jc.2005-1990
26. Sun L., Zhao Y., Li X., Yuan H., Cheng A., Lou H., A lysosomal- mitochondrial death pathway is induced by solamargine in human K562 leukemia cells. Toxicology in Vitro 2010 24 6 1504 1511 2-s2.0-77956180671 10.1016/j.tiv.2010.07.013
27. Ding X., Zhu F. S., Li M., Gao S. G., Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L. Journal of Ethnopharmacology 2012 139 599 604
28. Gagnon V., Mathieu I., Sexton É., Leblanc K., Asselin E., AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gynecologic Oncology 2004 94 3 785 795 2-s2.0-4444346646 10.1016/j.ygyno.2004. 06.023 (Pubitemid 39194476)
29. Mhaidat N. M., Wang Y., Kiejda K. A., Zhang X. D., Hersey P., Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2. Molecular Cancer Therapeutics 2007 6 2 752 761 2-s2.0-33847368592 10.1158/1535-7163.MCT-06-0564 (Pubitemid 46332476)
30. Kolfschoten G. M., Hulscher T. M., Duyndam M. C. A., Pinedo H. M., Boven E., Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel. Biochemical Pharmacology 2002 63 4 733 743 2-s2.0-0037085048 10.1016/S0006-2952(01)00895-4 (Pubitemid 34457705)
31. Muenchen H. J., Poncza P. J., Pienta K. J., Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3. Urology 2001 57 2 366 370 2-s2.0-0035136614 10.1016/S0090-4295(00)00935-3 (Pubitemid 32140833)
32. Rouette A., Parent S., Girouard J., Leblanc V., Asselin E., Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells. International Journal of Cancer 2012 130 1755 1767
33. Lin H. M., Tseng H. C., Wang C. J., Lin J. J., Lo C. W., Chou F. P., Hepatoprotective effects of Solanum nigrum Linn extract against CCl4-iduced oxidative damage in rats. Chemico-Biological Interactions 2008 171 3 283 293 2-s2.0-38549164873 10.1016/j.cbi.2007.08.008 (Pubitemid 351163224)